DIH Holdings US, Inc Class A (DHAI) AI Stock Analysis

• Market Cap: $9.37M
• Dividend Yield: N/A
• Average Volume (3M): 1.61M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.92
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 192
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Devices
• EPS (TTM): -0.32
• Shares Outstanding: 47,336,304
• 10 Day Avg. Volume: 2,631,270
• 30 Day Avg. Volume: 1,612,590
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 8.55
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: 2.69
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

DIH Holdings US, Inc faces significant challenges with negative profitability and equity, compounded by bearish technical indicators and unattractive valuation metrics. The recent board member resignation adds to corporate governance concerns, overshadowing positive cash flow improvements.

DIH Holdings US, Inc Class A Business Overview & Revenue Model

Company Description

DIH Holding US, Inc. operates as a robotics and virtual reality technology provider in the rehabilitation and human performance industry. The company is based in Norwell, Massachusetts.

How the Company Makes Money

null

DIH Holdings US, Inc Class A Financial Statement Overview

Summary

DIH Holdings US, Inc Class A shows strong revenue growth, but ongoing financial challenges with negative profitability and equity. Despite positive cash flow improvements, the overall financial health remains concerning.

Income Statement

The company shows a positive revenue growth trajectory with a 22% increase from 2022 to the TTM 2024. However, profitability remains a concern with a negative net profit margin of -13.3% and a decreasing gross profit margin at 48%. EBIT and EBITDA margins are also negative, indicating operational inefficiencies. Despite the revenue growth, the persistent negative margins highlight ongoing financial struggles.

Balance Sheet

The balance sheet presents significant challenges with a negative stockholders' equity of -$37.9 million, suggesting financial instability. The debt-to-equity ratio cannot be calculated due to negative equity, but the total debt is substantial at $15 million. The equity ratio is also negative, indicating that liabilities exceed assets. These factors point to potential financial distress.

Cash Flow

The cash flow statement shows a positive operating cash flow of $2.4 million in TTM 2024, indicating improved cash management. The free cash flow is also positive at $1.9 million, with a healthy operating cash flow to net income ratio of -0.27, reflecting better cash generation relative to reported losses. However, the free cash flow growth rate is negative, showing a decline from the previous year.

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
64.47M	55.00M	49.04M	47.52M
	Gross Profit
29.77M	34.54M	24.77M	28.23M
	EBIT
-2.61M	-218.00K	-10.46M	-10.54M
	EBITDA
-6.20M	652.00K	-9.46M	-9.63M
	Net Income Common Stockholders
-8.44M	-2.36M	-12.05M	-10.85M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
3.23M	5.56M	3.31M	3.16M
	Total Assets
35.73M	37.43M	34.02M	38.78M
	Total Debt
15.95M	18.20M	23.63M	17.09M
	Net Debt
12.72M	12.64M	20.32M	13.94M
	Total Liabilities
68.28M	66.49M	60.44M	54.96M
	Stockholders Equity
-32.55M	-29.05M	-26.42M	-16.18M
Cash Flow		Free Cash Flow
4.99M	6.02M	-1.71M	-5.74M
	Operating Cash Flow
5.19M	6.18M	-744.00K	-4.99M
	Investing Cash Flow
-202.00K	-163.00K	-969.00K	-1.12M
	Financing Cash Flow
-4.95M	-3.66M	2.04M	2.16M

DIH Holdings US, Inc Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DHAI, the sentiment is Negative. The current price of 0.2 is above the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.27, and below the 200-day MA of 1.33, indicating a neutral trend. The MACD of -0.03 indicates Negative momentum. The RSI at 40.79 is Neutral, neither overbought nor oversold. The STOCH value of 29.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DHAI.

DIH Holdings US, Inc Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	56 Neutral	$4.37B	7.13	-18.54%	5.13%	19.90%	-56.51%
NURO	45 Neutral	$9.43M	―	-45.38%	―	-48.61%	32.18%
TNON	44 Neutral	$7.25M	―	-405.19%	―	11.92%	87.83%
DHAI	41 Neutral	$9.37M	―	9.26%	―	―	―
AEMD	38 Underperform	$6.43M	―	-160.04%	―	-100.00%	68.26%
MOVE	23 Underperform	$6.23M	―	-439.23%	―	―	56.73%

DIH Holdings US, Inc Class A Corporate Events

Kenneth E. Ludlum Resigns from DIH Holdings Board

On April 30, 2025, Kenneth E. Ludlum resigned from the Board of Directors of DIH Holdings US, Inc., with his departure not stemming from any disagreements over the company’s operations, policies, or practices. The company has yet to decide on a replacement for the vacancy left by Mr. Ludlum’s resignation.

Spark’s Take on DHAI Stock

According to Spark, TipRanks’ AI Analyst, DHAI is a Neutral.

DIH Holdings US, Inc faces significant challenges with negative profitability and equity, compounded by bearish technical indicators and unattractive valuation metrics. The recent board member resignation adds to corporate governance concerns, overshadowing positive cash flow improvements.

To see Spark’s full report on DHAI stock, click here.

DIH Holdings US, Inc Announces Board Member Resignation

On February 25, 2025, Dr. Patrick Bruno resigned from the Board of Directors of DIH Holding US, Inc., as well as from his roles at its subsidiaries, including Hocoma Medical GmbH and Hocoma AG. The company will not immediately fill his position, reducing the board size to five members. Dr. Bruno’s resignation followed violations of company policies, and a Termination Agreement was established, which includes mutual releases, confidentiality, and non-disparagement clauses. He will receive his salary up to the resignation date but will not receive any bonuses or severance payment.